Copyright Reports & Markets. All rights reserved.

Global Opioids Drugs Market Research Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Opioids Drugs Market Overview

      • 1.1 Product Overview and Scope of Opioids Drugs
      • 1.2 Opioids Drugs Segment by Type
        • 1.2.1 Global Opioids Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Oxycodone
        • 1.2.3 Hydromorphone
        • 1.2.4 Codeine
        • 1.2.5 Fentanyl
        • 1.2.6 Other
      • 1.3 Opioids Drugs Segment by Application
        • 1.3.1 Opioids Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Pain Relief
        • 1.3.3 Anesthesia
        • 1.3.4 Other
      • 1.3 Global Opioids Drugs Market by Region
        • 1.3.1 Global Opioids Drugs Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Opioids Drugs Market Size
        • 1.4.1 Global Opioids Drugs Revenue (2014-2025)
        • 1.4.2 Global Opioids Drugs Production (2014-2025)

      2 Global Opioids Drugs Market Competition by Manufacturers

      • 2.1 Global Opioids Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Opioids Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Opioids Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Opioids Drugs Production Sites, Area Served, Product Types
      • 2.5 Opioids Drugs Market Competitive Situation and Trends
        • 2.5.1 Opioids Drugs Market Concentration Rate
        • 2.5.2 Opioids Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Opioids Drugs Production Market Share by Regions

      • 3.1 Global Opioids Drugs Production Market Share by Regions
      • 3.2 Global Opioids Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Opioids Drugs Production
        • 3.4.1 North America Opioids Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Opioids Drugs Production
        • 3.5.1 Europe Opioids Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Opioids Drugs Production (2014-2019)
        • 3.6.1 China Opioids Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Opioids Drugs Production (2014-2019)
        • 3.7.1 Japan Opioids Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Opioids Drugs Consumption by Regions

      • 4.1 Global Opioids Drugs Consumption by Regions
      • 4.2 North America Opioids Drugs Consumption (2014-2019)
      • 4.3 Europe Opioids Drugs Consumption (2014-2019)
      • 4.4 China Opioids Drugs Consumption (2014-2019)
      • 4.5 Japan Opioids Drugs Consumption (2014-2019)

      5 Global Opioids Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Opioids Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Opioids Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Opioids Drugs Price by Type (2014-2019)
      • 5.4 Global Opioids Drugs Production Growth by Type (2014-2019)

      6 Global Opioids Drugs Market Analysis by Applications

      • 6.1 Global Opioids Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Opioids Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Opioids Drugs Business

      • 7.1 Purdue Pharma
        • 7.1.1 Purdue Pharma Opioids Drugs Production Sites and Area Served
        • 7.1.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.1.3 Purdue Pharma Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 J&J
        • 7.2.1 J&J Opioids Drugs Production Sites and Area Served
        • 7.2.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.2.3 J&J Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Teva
        • 7.3.1 Teva Opioids Drugs Production Sites and Area Served
        • 7.3.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.3.3 Teva Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Mylan
        • 7.4.1 Mylan Opioids Drugs Production Sites and Area Served
        • 7.4.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.4.3 Mylan Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Depomed
        • 7.5.1 Depomed Opioids Drugs Production Sites and Area Served
        • 7.5.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.5.3 Depomed Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 INSYS
        • 7.6.1 INSYS Opioids Drugs Production Sites and Area Served
        • 7.6.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.6.3 INSYS Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Endo
        • 7.7.1 Endo Opioids Drugs Production Sites and Area Served
        • 7.7.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.7.3 Endo Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Pfizer
        • 7.8.1 Pfizer Opioids Drugs Production Sites and Area Served
        • 7.8.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.8.3 Pfizer Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Hikma
        • 7.9.1 Hikma Opioids Drugs Production Sites and Area Served
        • 7.9.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.9.3 Hikma Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Mallinckrodt
        • 7.10.1 Mallinckrodt Opioids Drugs Production Sites and Area Served
        • 7.10.2 Opioids Drugs Product Introduction, Application and Specification
        • 7.10.3 Mallinckrodt Opioids Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Pernix
      • 7.12 Egalet
      • 7.13 Vistapharm

      8 Opioids Drugs Manufacturing Cost Analysis

      • 8.1 Opioids Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Opioids Drugs
      • 8.4 Opioids Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Opioids Drugs Distributors List
      • 9.3 Opioids Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Opioids Drugs Market Forecast

      • 11.1 Global Opioids Drugs Production, Revenue Forecast
        • 11.1.1 Global Opioids Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Opioids Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Opioids Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Opioids Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Opioids Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Opioids Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Opioids Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Opioids Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Opioids Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Opioids Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Opioids Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Opioids Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Opioids Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Opioids Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Opioids Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Opioids Drugs market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Opioids Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Opioids Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Purdue Pharma
        J&J
        Teva
        Mylan
        Depomed
        INSYS
        Endo
        Pfizer
        Hikma
        Mallinckrodt
        Pernix
        Egalet
        Vistapharm

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Oxycodone
        Hydromorphone
        Codeine
        Fentanyl
        Other

        Segment by Application
        Pain Relief
        Anesthesia
        Other

        Buy now